Company Profile

Company Description

Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer treatment. Its lead product candidate is designed to target breast cancer by stimulating the immune system to attack tumor cells. The company emphasizes personalized medicine, leveraging cutting-edge research to improve patient outcomes. With a strong pipeline, it aims to address unmet medical needs in oncology through novel therapeutic approaches.